Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NYSE: SOLV) | Delayed: 86.67 -0.78 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.45 | 52 Week High | $ | |||
| Open | $86.92 | 52 Week Low | $ | |||
| Day High | $87.27 | P/E | N/A | |||
| Day Low | $86.46 | EPS | $ | |||
| Volume | 19,339 | |||||
